Large-scale testing (Phase 3)Active Not RecruitingNCT03998254
What this trial is testing
Efficacy, Immunogenicity and Safety of V503 in Chinese Women Aged 20-45 Years (V503-023)
Who this might be right for
Papillomavirus Infections
Merck Sharp & Dohme LLC 6,000